Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00249574 · ClinicalTrials.gov registry record · NA
Bridging Active Heroin Users to Hepatitis C Treatment Using Buprenorphine - 1
A NA study, sponsored by National Institute on Drug Abuse (NIDA).
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT00249574 is a NA study that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 10 participants.
The verdict
NCT00249574, a NA study, has completed, sponsored by National Institute on Drug Abuse (NIDA).
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The purpose of this study is to see whether street-recruited heroin users can be successfully treated for hepatitis C after stabilizing them on buprenorphine.
Interventions
- DRUG Buprenorphine/naloxone
- DRUG pegInterferon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2003-06 |
| Est. Completion | 2006-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00249574
The ClinicalTrials.gov registry entry for NCT00249574 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Buprenorphine/naloxone is the first listed.
NCT00249574 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00249574 about?
NCT00249574 is a clinical study titled "Bridging Active Heroin Users to Hepatitis C Treatment Using Buprenorphine - 1". The purpose of this study is to see whether street-recruited heroin users can be successfully treated for hepatitis C after stabilizing them on buprenorphine.
What is the current status of trial NCT00249574?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2003-06. Estimated completion is 2006-06.
What interventions are being tested in trial NCT00249574?
The interventions under investigation include: Buprenorphine/naloxone (DRUG), pegInterferon (DRUG).
Who is sponsoring clinical trial NCT00249574?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.